Lp(a) Therapies Show Promise in Reducing Cardiovascular Risk Key Points Lipoprotein(a), or Lp(a), is identified as an independent risk factor for heart disease. New therapies are in growth to specifically target and lower Lp(a) levels. Clinical trials are underway to determine if lowering lp(a) reduces cardiovascular events. Lp(a) Therapies Show Promise in Reducing Cardiovascular risk […]
The post Lp(a) Reduction: New ASCVD Therapies appeared first on News Directory 3.